Wearable Artificial Kidney

A wearable artificial kidney could be developed as a viable, new dialysis technology that allows patients to be mobile and untethered during treatment.

A wearable artificial kidney could be developed as a viable, new dialysis technology that allows patients to be mobile and untethered during treatment, results of a US Food and Drug Administration-authorised clinical trial suggest. The technology may become an alternative to conventional hemodialysis for people with end-stage kidney disease. Presen...

A wearable artificial kidney may be a viable dialysis technology that can give people with end-stage kidney disease the freedom to move around during treatment, according to the results of a new clinical trial.

The technology may become an alternative to conventional hemodialysis for people with end-stage kidney disease.

A wearable artificial kidney could be developed as a viable, new dialysis technology that allows patients to be mobile and untethered during treatment, results of a US Food and Drug Administration-authorised clinical trial suggest.

A wearable artificial kidney could be developed as a viable, new dialysis technology that allows patients to be mobile and untethered during treatment.

A wearable artificial kidney could be developed as a viable, new dialysis technology that allows patients to be mobile and untethered during treatment, results of a US Food and Drug Administration-authorised clinical trial suggest. The technology may become an alternative to conventional hemodialysis for people with end-stage kidney disease. Presen...

A wearable artificial kidney may be a viable dialysis technology that can give people with end-stage kidney disease the freedom to move around during treatment, according to the results of a new clinical trial.

The technology may become an alternative to conventional hemodialysis for people with end-stage kidney disease.

A wearable artificial kidney could be developed as a viable, new dialysis technology that allows patients to be mobile and untethered during treatment, results of a US Food and Drug Administration-authorised clinical trial suggest.